Geode Capital Management
CDIO icon

Geode Capital Management’s Cardio Diagnostics CDIO Stock Holding History

Geode Capital Management’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.7K Buy
32,177
+17,042
+113% +$44.6K ﹤0.01% 4261
2025
Q4 		$41K Buy
15,135
+37
+0.2% +$135 ﹤0.01% 4269
2025
Q3 		$60.8K Buy
15,098
+1,733
+13% +$6.84K ﹤0.01% 4248
2025
Q2 		$48.1K Buy
13,365
+198
+2% +$1.48K ﹤0.01% 4227
2025
Q1 		$130K Buy
13,167
+1,021
+8% +$15.9K ﹤0.01% 3960
2024
Q4 		$334K Buy
12,146
+5,999
+98% +$83.2K ﹤0.01% 3726
2024
Q3 		$41.1K Buy
6,147
+329
+6% +$4.04K ﹤0.01% 4299
2024
Q2 		$96K Buy
5,818
+742
+15% +$17.5K ﹤0.01% 4151
2024
Q1 		$216K Buy
5,076
+462
+10% +$26.3K ﹤0.01% 3919
2023
Q4 		$345K Buy
4,614
+2,098
+83% +$72.6K ﹤0.01% 3742
2023
Q3 		$25.7K Hold
2,516
– – ﹤0.01% 4577
2023
Q2 		$89.8K Buy
2,516
+40
+2% +$2.26K ﹤0.01% 4369
2023
Q1 		$290K Buy
+2,476
New +$195K ﹤0.01% 3875

Other funds holding CDIO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Geode Capital Management's CDIO Position: Q1 2026 in Review

Geode Capital Management increased its Cardio Diagnostics (CDIO) stake by 113% in Q1 2026, buying an estimated $44.6K and bringing the position to 32,177 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4261.

Geode Capital Management first reported a position in CDIO in Q1 2023 and has held it in 13 quarters since. The position peaked at $345K in Q4 2023. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • Geode Capital Management held 32,177 shares of Cardio Diagnostics worth $62.7K as of Q1 2026.
  • Geode Capital Management bought 17,042 Cardio Diagnostics shares in Q1 2026, an estimated $44.6K.
  • Cardio Diagnostics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4261 holding.
  • Geode Capital Management first reported a position in Cardio Diagnostics in Q1 2023 and has held it in 13 quarters since.
  • Geode Capital Management's Cardio Diagnostics position peaked at $345K in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.